Clinical Trials in Chicago

Showing 9881-9900 of 20,493 trials

The Intensive Comprehensive Aphasia Program (ICAP)

NCT03514186

The purpose of this study is to conduct a randomized clinical trial that assesses the efficacy and cost-effectiveness of an Intensive Comprehensive Aphasia Program (ICAP), specifically focusing on the variable of intensity. Half of the participants will receive 60 hours of intensive treatment over three weeks, while the other half will receive the same amount and type of comprehensive treatment distributed over 15 weeks.

AphasiaStroke

Shirley Ryan AbilityLab56 participantsStarted Jul 2015

Chicago, Illinois, United States

TERMINATEDPhase 32.2 miles

Surgical Idiopathic Intracranial Hypertension Treatment Trial

NCT03501966

Randomized trial of adults (≥18 years old) with idiopathic intracranial hypertension and moderate to severe visual loss without substantial recent treatment who are randomly assigned to (1) medical therapy, (2) medical therapy plus ONSF, or (3) medical therapy plus VPS. The primary outcome is visual field mean deviation change at first of Month 6 (26 weeks) or time of treatment failure of the eligible eye(s), followed by a continuation study to assess time to treatment failure. The determination of eligible eye(s) is based on meeting the eligibility criteria at baseline.

Idiopathic Intracranial Hypertension

Jaeb Center for Health Research7 participantsStarted Feb 2019

Los Angeles, California, United States • Los Angeles, California, United States • Palo Alto, California, United States +33 more locations

The Intensive Comprehensive Aphasia Program (ICAP)

Surgical Idiopathic Intracranial Hypertension Treatment Trial

Find Trials by Condition in Chicago

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

Safety and Tolerability Study of IV ST266 in COVID-19 Subjects

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal

The Missouri Health Literacy and Diabetes Communication Initiative

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)

A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine

A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis

Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization in Patients With an Inspire Upper Airway Stimulation System (Comparison of Home Sleep Testing vs. In-lab Polysomnography Testing)

Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain

Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy